AR240935A1 - Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales. - Google Patents

Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales.

Info

Publication number
AR240935A1
AR240935A1 AR300752A AR30075285A AR240935A1 AR 240935 A1 AR240935 A1 AR 240935A1 AR 300752 A AR300752 A AR 300752A AR 30075285 A AR30075285 A AR 30075285A AR 240935 A1 AR240935 A1 AR 240935A1
Authority
AR
Argentina
Prior art keywords
guanidinotiazole
tiadiazole
alkyltio
alkylamine
salts
Prior art date
Application number
AR300752A
Other languages
English (en)
Spanish (es)
Other versions
AR240935A2 (es
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of AR240935A2 publication Critical patent/AR240935A2/es
Publication of AR240935A1 publication Critical patent/AR240935A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AR300752A 1984-06-22 1985-06-19 Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales. AR240935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (2)

Publication Number Publication Date
AR240935A2 AR240935A2 (es) 1991-03-27
AR240935A1 true AR240935A1 (es) 1991-03-27

Family

ID=24498651

Family Applications (1)

Application Number Title Priority Date Filing Date
AR300752A AR240935A1 (es) 1984-06-22 1985-06-19 Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales.

Country Status (33)

Country Link
US (1) US4644006A (fi)
JP (2) JPS6118775A (fi)
KR (1) KR900004321B1 (fi)
AR (1) AR240935A1 (fi)
AT (1) AT390790B (fi)
AU (2) AU580605B2 (fi)
BE (1) BE902724A (fi)
CA (2) CA1267412A (fi)
CH (1) CH665210A5 (fi)
CS (1) CS257276B2 (fi)
DD (1) DD240889A5 (fi)
DE (1) DE3522101A1 (fi)
DK (1) DK282885A (fi)
ES (2) ES8702902A1 (fi)
FI (1) FI852405L (fi)
FR (1) FR2566406B1 (fi)
GB (2) GB2161157B (fi)
GR (1) GR851514B (fi)
HU (1) HU193992B (fi)
IE (2) IE57937B1 (fi)
IL (1) IL75567A0 (fi)
IT (1) IT1190372B (fi)
LU (1) LU85969A1 (fi)
NL (1) NL8501766A (fi)
NO (1) NO161856C (fi)
NZ (1) NZ212403A (fi)
OA (1) OA08039A (fi)
PT (1) PT80684B (fi)
SE (1) SE464305B (fi)
SU (1) SU1537136A3 (fi)
YU (2) YU45725B (fi)
ZA (1) ZA854710B (fi)
ZW (1) ZW10385A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
NL189197C (nl) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten.
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
DE3168031D1 (en) * 1980-07-30 1985-02-14 Ici Plc Guanidine derivatives
EP0060730A3 (en) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclic derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
NL8301063A (nl) * 1982-03-29 1983-10-17 Bristol Myers Co Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden.
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
CS257276B2 (en) 1988-04-15
AR240935A2 (es) 1991-03-27
AU614331B2 (en) 1991-08-29
CA1297875C (en) 1992-03-24
KR900004321B1 (ko) 1990-06-22
SE464305B (sv) 1991-04-08
ES8702902A1 (es) 1987-01-16
FI852405A0 (fi) 1985-06-17
ES544409A0 (es) 1987-01-16
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
GB8515749D0 (en) 1985-07-24
CH665210A5 (de) 1988-04-29
DD240889A5 (de) 1986-11-19
HUT42087A (en) 1987-06-29
OA08039A (fr) 1987-01-31
HU193992B (en) 1987-12-28
JPS6118775A (ja) 1986-01-27
IE58261B1 (en) 1993-08-25
SE8503110L (sv) 1985-12-23
KR860000275A (ko) 1986-01-27
IT1190372B (it) 1988-02-16
LU85969A1 (fr) 1986-01-24
AU4392085A (en) 1986-01-02
IT8521217A0 (it) 1985-06-20
YU45725B (sh) 1992-07-20
IE851557L (en) 1985-12-22
ATA185885A (de) 1989-12-15
JPS61186369A (ja) 1986-08-20
GB2161157A (en) 1986-01-08
ZA854710B (en) 1986-02-26
AU2977589A (en) 1989-06-01
YU45822B (sh) 1992-07-20
GB2192884A (en) 1988-01-27
NO161856B (no) 1989-06-26
SE8503110D0 (sv) 1985-06-20
BE902724A (fr) 1985-12-23
ZW10385A1 (en) 1986-02-05
ES8702881A1 (es) 1987-01-16
US4644006A (en) 1987-02-17
ES551506A0 (es) 1987-01-16
GB2192884B (en) 1988-08-10
GR851514B (fi) 1985-11-25
IL75567A0 (en) 1985-10-31
NZ212403A (en) 1989-04-26
YU102587A (en) 1988-02-29
SU1537136A3 (ru) 1990-01-15
CA1267412A (en) 1990-04-03
FR2566406B1 (fr) 1988-01-29
PT80684A (en) 1985-07-01
DE3522101A1 (de) 1986-01-02
FI852405L (fi) 1985-12-23
DK282885A (da) 1985-12-23
AU580605B2 (en) 1989-01-19
PT80684B (en) 1987-05-08
CS424785A2 (en) 1987-09-17
YU105185A (en) 1987-12-31
IE57937B1 (en) 1993-05-19
GB2161157B (en) 1988-08-10
NO852519L (no) 1985-12-23
DK282885D0 (da) 1985-06-21
AT390790B (de) 1990-06-25
FR2566406A1 (fr) 1985-12-27
GB8716149D0 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
ES520849A0 (es) Procedimiento para preparar n2-acil-9-(1,3-dihidroxi-2-propoximetil)-guaninas y sus sales famaceuticamente aceptables.
ES551538A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidro-4-oxonaftiridina y sus sales
AR240806A1 (es) Procedimiento para la elaboracion de acidos 3-amino-(1)benzazepin- 2-ona-1-alcanoicos y sus sales.
NO864993D0 (no) 2-((3,5-dihalo-4-aminobenzyl))imidazoliner.
AR222828A1 (es) Procedimiento para la preparacion de 2,3,4,5-tetrahidro-6-feniltio-1h-3-benzazepinas y sus sales
AR240458A1 (es) Procedimeinto para preparar acidos 7-substituido-1-alquilo o cilcoalquilo-5,6,8-trifluor-1,4-dihidro-4-oxo-3-quinolincarboxilicos.
ES512969A0 (es) "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
ES515191A0 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
ES546619A0 (es) Derivados de 2,3-dihidro-1h-indeno y sus sales
AR240918A1 (es) "procedimiento para obtener novedosos derivados de carboestirilo y sus sales."
AR240924A1 (es) "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales".
ES547717A0 (es) Procedimiento para preparar sales de ciclimonio
ES515589A0 (es) "procedimiento para la preparacion de nuevos 2-(hidroxi-fenil)-indoles".
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
ES511329A0 (es) "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".
ES540777A0 (es) Procedimiento para preparar sales de derivados de oxazafos- forina
AR240935A1 (es) Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales.
ES519853A0 (es) Un procedimiento para la preparacion de derivados de anilinay sus sales.
ES512397A0 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".
AR241137A1 (es) "procedimiento para preparar beta-metilen-2 o 3-tiofenetanamina".
AR240822A1 (es) Un procedimiento para la preparacion de una trans-octahidro-oxazolo|4,5-g¨quinolina y sus sales
ES508585A0 (es) "procedimiento para la preparacion de 3-picolina".
AR228852A1 (es) Procedimiento para preparar derivados de 1,1'bifenil-2-il-alquilamina y sus sales
ES540147A0 (es) Procedimiento para la obtencion del 2-(2-(3,5-dimetil-4-me- toxi)piridilmetil sulfonil)-5-metoxibenzimidazol
ES514464A0 (es) "un procedimiento de preparacion de amino-4-butiramida y sus sales".